FATE EBITDA Margin

Fate Therapeutics Inc · EBITDA Margin

FATE logo

FATE EBITDA Margin

Latest reported-1762.49%
FATE EBITDA Margin (-1079.32% → -1762.49%)
High-resolution chart · PNG

FATE ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-1,911.2248%
-1,295.4075%
-224.5227%
-278.2586%
-369.4105%
-397.6522%
-882.0599%
-1,343.8397%
-991.549%
-702.9532%
-1,114.1506%
0%
-2,011.0196%
-492.9588%
-1,079.3162%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.